B. Riley Lowers Journey Medical's Price Target to $6 From $10 After Q3 Topline Miss on Generic Competition, Keeps Buy Rating
B. Riley Lowers Journey Medical's Price Target to $6 From $10 After Q3 Topline Miss on Generic Competition, Keeps Buy Rating
在第三季度仿製藥競爭失敗後，B. Riley將Journey Medical的目標股價從10美元下調至6美元，維持買入評級
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊